- Thesis
- The market prices Marex above the AI estimate, because it expects Marex to keep most of its record profit of 2026. In the first half of 2026, very high commodity volatility made market making and trading unusually profitable. But Q2 2026 was also a record quarter in calmer markets, and clearing balances, prime services and acquisitions keep adding fee and interest income. The AI estimate gives equal weight to two cases: profit goes back to the 2025 level plus growth, or the first-half 2026 level is the new base. Trust issues hold the price back. A short seller accused Marex of accounting manipulation in August 2025, and the 2025 annual report showed two material weaknesses in internal control. Falling interest rates also reduce the interest Marex earns on client cash. For the price to hold, adjusted profit must keep growing in quarters with normal volatility, and there must be no large new client default. The 2026 annual report must also show that the control weaknesses are fixed. If profit falls back toward the 2025 level when volatility eases, the price can fall to the AI estimate or below. The evidence arrives with the Q3 2026 results, expected in November 2026, the closing of the Bright Point and Brainchild acquisitions in late 2026 or early 2027, and the 2026 annual report in March 2027. Over the next three to five quarters, these reports show which of the two cases is correct.
- Valuation
- The fair value, the moat and the uncertainty on this page for Marex are an AI estimate from October 8, 2026. They are not an analyst's values. An AI research agent calculated them from Marex's filings. The method is a price-to-earnings multiple on adjusted diluted earnings per share (EPS) for the next 12 months. It uses two cases, and each case has a weight of 50%. These weights are an assumption. Case 1 assumes that the very high trading income of the first half of 2026 does not continue. It starts from the 2025 adjusted diluted EPS of $3.99, from the Q4 2025 results of March 3, 2026, and adds 10% growth to get $4.39. Case 2 assumes that the first-half 2026 level is the new base. It starts from adjusted diluted EPS of $5.17 for the 12 months to June 30, 2026. This is $3.13 for the first half of 2026, from the Q2 2026 results of August 12, 2026, plus $2.04 for the second half of 2025 ($3.99 less $1.95 for the first half of 2025). It adds 10% growth to get $5.69. The growth rate of 10% is an assumption. Both cases use a multiple of 14 times earnings. This multiple is also an assumption. It is about the multiple that a return on equity of 28%, a cost of equity of 11% and long-term growth of 5% give. The adjusted return on equity was 29.9% in 2025. Case 1 gives about $61.45 per share and Case 2 gives about $79.62 per share. The average of the two cases is about $70.50 per share. Net trading income in the first half of 2026 was $727.1 million, double the $362.4 million of a year earlier, so the profit base is not certain. The two material weaknesses in internal control and the risk of client defaults add more doubt. For these reasons, the uncertainty is High. The moat rating is None. The 2025 annual report of March 25, 2026 says that the markets of Marex are highly competitive. It also says that some competitors are banks and brokers with more clients and more money. Marex has access to more than 60 exchanges and over 3,400 active clients. It is a Category 1 member of the London Metal Exchange (LME), which has only a small number of members. These give some scale. But the report also says that competitors tryMarex can lose brokers to hire away thecompetitors, and that brokers who hold theleave can take client relationships with them. Thus the switching costs belong partly to the staff, not to the company. Clients can also clear through other firms or become exchange members. Profit depends much on volatility: net trading income rose to $851.9 million in 2025 from $492.4 million in 2024. The adjusted return on equity of 29.9% in 2025 is high, but the estimate does not find clear evidence that it lasts 10 years or more. On October 12, 2026, a second check of all inputs against the filings found no errors. No new results were published after the estimate. From Q2 2026, adjusted EPS deducts the coupon on the 7.70% hybrid notes, about $38.5 million a year before tax. This lowers future adjusted EPS by up to about $0.40 per share a year (an estimate, before any tax relief on the coupon). The estimate does not include this yet, so it can be a little high.
As of 2026-10-0812.
- Balance sheet
- Marex is a broker and clearing firm, so its balance sheet is large compared with its equity. At June 30, 2026, total assets were $42.1 billion and total equity was $1.87 billion. Of the equity, $1.37 billion belonged to ordinary shareholders, and $495 million was a 7.70% perpetual hybrid note that counts as equity. Most of the assets are matched client positions, such as stock lending, repos and client margin. They are not money that Marex owes for its own use. Debt securities were $6.85 billion at June 30, 2026. But $4.91 billion of this was structured notes sold to investors, with an average expected lifematurity of about 15 months. Many of these notes fall due within 12 months, and Marex sells new notes to replace them. These notes can leave quickly in stress. Marex also had $432 million of short-term borrowings that lenders can call on demand. The corporate debt is $1.59 billion of senior notes, swapped to floating rates, plus EUR 300 million of EMTN notes. The first largebond maturities come in 2028. S&P rates the group BBB- (stable, affirmed in September 2025), and Fitch rates it BBB- (positive outlook since April 2025). The check on October 12, 2026 found no rating action after the July 2026 move to Bermuda. Marex had $490 million of undrawn committed credit lines, from a new facility of June 30, 2026. It reported $1.81 billion of liquidity above its own internal requirement at June 30, 2026. Its capital surplus over the requirement was $978 million (287%), but this includes the new hybrid. Since the July 2026 move to Bermuda, management sets the group measure, not the UK regulator. The balance sheet gives room for small acquisitions. But the real limit is the trust of clients and lenders. A large client default or a run on structured notes would use up capital quickly.
As of 2026-06-30.
- Recent events
- 2026-10-07: Marex said that Robert Pickering left the Group Board at the end of his three-year term as Chair. He was Chair from October 2023. John Pietrowicz became Chair. He joined the board in April 2024 and was CFO of CME Group from 2014 to 2023.
2026-09-09: Marex paid a quarterly dividend of $0.16 per share for Q2 2026, up from $0.15 for Q4 2025.
2026-08-21: Marex agreed to pay $950,000 to settle a US class action that repeated the claims of the short seller's claims NINGI Research. The plaintiffs asked the court for preliminary approval. The settlement still needs final court approval.
2026-08-12: Marex reported Q2 2026 results. Revenue was $695.8 million, up 39%. Adjusted profit before tax was $165.9 million, up 56%. ManagementOn the results call, the CEO said profit growththat he is confident that Marex can grow at least in line with the top of its 10% to 20% target range is likelyfor profit growth. From Q2 2026, adjusted earnings per share deduct the coupon on the new hybrid notes.
2026-08-10: Marex agreed to buy Brainchild Capital Investments, a Dutch energy and environmental clearing firm that clears and executes power and gas trades. The former private equityCompletion is expected in late 2026 or early 2027. On the same day, the two largest owners reportedfrom before the listing filed reports that they held no longer hold Marex shares at June 30, 2026.
2026-08-03: Marex completed its purchase of Webb Traders, a European equity derivatives market maker, for an initial payment of EUR 69.9 million.
2026-07-09: Marex agreed to buy Bright Point International, a Singapore clearing firm with about $800 million of client balances. Completion is expected in late 2026 or early 2027.
2026-07-01: Marex moved its parent company from England and Wales to Bermuda. The group is no longer under the UK FCA's group capital rules. Its regulated subsidiaries stay under their own regulators.
2026-06-09: Marex issued $500 million of perpetual hybrid notes at 7.70% and. By June 11, it bought back most$94.7 million of its $100 million of 13.25% AT1 notes at 109% of their face value.
2026-05-06: Marex reported Q1 2026 results. Adjusted profit before tax was $152.7 million, up 59%. A natural gas client default in January caused a $3433.9 million loss in Clearing.
2026-03-25: Marex filed its 2025 annual report. Management and the auditor reported two material weaknesses in internal control, in IT access and in balance sheet reconciliations.